Sentinus, LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sentinus, LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,241,181
-11.9%
167,275
+12.2%
0.39%
-16.8%
Q1 2023$1,408,523
+418.6%
149,050
+548.0%
0.47%
+196.2%
Q4 2022$271,575
+63.6%
23,000
+2.2%
0.16%
+52.9%
Q3 2022$166,00022,5000.10%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$702,0000.41%
Rubric Capital Management LP 294,683$2,299,0000.17%
Interchange Capital Partners, LLC 24,420$190,0000.10%
GOODWIN DANIEL L 20,000$156,0000.09%
Consonance Capital Management LP 88,428$690,0000.06%
DCM Advisors, LLC 13,300$104,0000.06%
Virtu Financial LLC 27,524$215,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 68,899$537,0000.01%
Lindbrook Capital, LLC 1,000$8,0000.00%
ExodusPoint Capital Management, LP 11,900$93,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders